Featured Publications
Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
McPadden J, Warner F, Young HP, Hurley NC, Pulk RA, Singh A, Durant TJS, Gong G, Desai N, Haimovich A, Taylor RA, Gunel M, Dela Cruz CS, Farhadian SF, Siner J, Villanueva M, Churchwell K, Hsiao A, Torre CJ, Velazquez EJ, Herbst RS, Iwasaki A, Ko AI, Mortazavi BJ, Krumholz HM, Schulz WL. Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection. PLOS ONE 2021, 16: e0243291. PMID: 33788846, PMCID: PMC8011821, DOI: 10.1371/journal.pone.0243291.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionYale New Haven HealthSARS-CoV-2Hospital mortalityRisk of admissionMale sexRisk factorsSARS-CoV-2 testingInvasive mechanical ventilationSevere acute respiratory syndrome virusBurden of diseaseRT-PCR testingAcademic health systemDiverse patient populationsRespiratory syndrome virusEthnic groupsAdult patientsClinical characteristicsDischarge dispositionRespiratory supportPrimary outcomeTreatment guidelinesMechanical ventilationRetrospective studyPatient population
2019
Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
Bahar B, Schulz WL, Gokhale A, Spencer BR, Gehrie EA, Snyder EL. Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets. British Journal Of Haematology 2019, 188: 465-472. PMID: 31566724, PMCID: PMC7003815, DOI: 10.1111/bjh.16187.Peer-Reviewed Original ResearchConceptsPathogen-reduced plateletsTransfusion reactionsPlatelet componentsAdult patientsPlatelet transfusionsSeptic transfusion reactionsRed blood cell transfusion requirementsPR plateletsYale-New Haven HospitalPlatelet component transfusionsComparable clinical efficacyType of transfusionTransfusion requirementsTransfusion trendsPlatelet administrationComponent transfusionClinical efficacyNumber of RBCsConventional plateletsBlood utilisationPatientsTransfusionMean timePlateletsRBCs